drugset

drugset / Trial / NCT00293917

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293917 ↗

Phase 3 Completed 658 enrolled Astellas Pharma Inc Astellas Pharma US, Inc. · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study to assess the long-term safety of tacrolimus cream in the treatment of psoriasis

Timeline

Start: 2006-01
Primary completion: 2007-08
Completion: 2007-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	0.1 %	—

Indications